About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 203 record(s)
Req # 2000-2-A-2024-01-A
Any document or information either created or obtained by your organization concerning the “Politically Exposed Person” (“PEP”) status conferred upon individuals in Canada or elsewhere.Organization: Office of the Intelligence Commissioner
February 2024
Req # A-2024-54596
Submission of the Public Health Agency of Canada (PHAC) to the Patented Medicine Prices Review Board’s November 2023 consultation on the Scoping paper of the Board's Guidelines. Submissions from other stakeholders can be viewed here: https://…Organization: Patented Medicine Prices Review Board Canada
February 2024
Req # A-2021-024942
Provide all emails sent to/from/cc'ing Douglas Clarke between May 1 to December 16, 2021. Exclude media scans.Organization: Patented Medicine Prices Review Board Canada
September 2023
Req # A-2023-36126
When referring to page numbers below, I mean the pages in the Client Package disclosed under A-2022-05111. Specifically, I would like to request the following: 1. The "Board deck" (presumably a PowerPoint presentation) mentioned on pages…Organization: Patented Medicine Prices Review Board Canada
September 2023
Req # 2000-2-A-2023-01-A
For fiscal years 2021-2022, how many times was the Office of the Intelligence Commissioner briefed, by the Minister of National Defence and the Minister of Public Safety and Emergency Preparedness, on the Ottawa trucker convoy?Organization: Office of the Intelligence Commissioner
July 2023
Req # 2000-2-A-2023-02-A
Please provide the following information. How much of the budget of the Office of the Intelligence Commissioner annually for fiscal years 2015-2022 (inclusive), went towards living expenses for sitting intelligence commissioners? Please provide…Organization: Office of the Intelligence Commissioner
July 2023
Req # 2000-2-A-2023-03-A
For fiscal years 2017-2022 (inclusive) what was the breakdown, by number and percentage, of activities by the Communication Security Establishment and the Canadian Security Intelligence Service that were not approved as compared to approved by the…Organization: Office of the Intelligence Commissioner
July 2023
Req # A-2022-05111
Electronic copies of the following documents. In all cases, cabinet confidences may be excluded and draft versions of documents. In all of the requests below, “draft guidelines” refers to the PMPRB Guidelines that were published for comment on…Organization: Patented Medicine Prices Review Board Canada
July 2023
Req # A-2023-025211
With regard to the c. 2003 HDAP Report on New Patented Drug - Angiomax (http://www.pmprbcepmb.gc.ca/view.asp?ccid=583), I am looking for a copy of any supporting research, reports and calculations used to determine dosage regimens. I am specifically…Organization: Patented Medicine Prices Review Board Canada
July 2023
Req # A-2023-025599
For FY 2015-2022 (inclusive), how many investigations into prescription pricing on the basis that the pricing exceeded the guidelines resulted in a public hearing? Of those that resulted in a public hearing, in how many was the pricing found to be…Organization: Patented Medicine Prices Review Board Canada
July 2023